How long does Ativan (lorazepam) take to work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onset of Action for Intramuscular Lorazepam

Intramuscular (IM) lorazepam begins to work within 15-20 minutes after injection, with peak effects occurring at approximately 60-90 minutes. 1

Pharmacokinetic Profile

The time course for IM lorazepam follows a predictable pattern:

  • Onset of action: 15-20 minutes after IM injection 1
  • Peak effect: Approximately 60 minutes (1 hour) after IM administration 1
  • Duration of effect: 6-8 hours 1

This contrasts with oral lorazepam, which has a longer onset time of 20-30 minutes and peaks at approximately 2 hours after administration. 1, 2

Clinical Context and Dosing

For acute agitation management in adolescents and adults, typical IM dosing is:

  • Adults: 2 mg IM, which may be repeated every 30-60 minutes as needed 1
  • Adolescents: 0.05-0.1 mg/kg IM 1

The relatively rapid onset makes IM lorazepam suitable for acute behavioral emergencies, though it is slower than IV administration (which acts within 5-10 minutes). 1

Important Clinical Considerations

Respiratory depression risk: The major adverse effect is dose-dependent respiratory depression, particularly when combined with opioids or in patients with underlying respiratory disease. 1 Close monitoring is essential after administration.

Duration considerations: While onset is relatively quick at 15-20 minutes, the elimination half-life is approximately 12 hours, meaning effects persist well beyond the initial peak. 2, 3 Patients require extended monitoring (up to 2 hours minimum) even after apparent recovery. 1

Paradoxical reactions: Younger patients and those with developmental disabilities may experience behavioral disinhibition rather than sedation. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of lorazepam: a review.

The Journal of clinical psychiatry, 1978

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.